Meiji Holdings Co ( (MEJHF) ) has released its Q2 earnings. Here is a breakdown of the information Meiji Holdings Co presented to its investors.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Meiji Holdings Co., Ltd. is a prominent player in the food and pharmaceutical industries, known for its diverse product offerings ranging from dairy and chocolate to pharmaceuticals and vaccines. In its latest earnings report for the first six months of the fiscal year ending March 2026, Meiji Holdings reported a modest increase in net sales to JPY 574.885 billion, marking a 1.0% rise from the previous year. However, the company faced challenges with a decline in operating profit by 7.8% to JPY 40.942 billion and a significant drop in profit attributable to owners of parent by 20.1% to JPY 21.477 billion. The food segment saw mixed results, with the chocolate and food solutions businesses showing growth, while the nutrition business faced declines. The pharmaceutical segment experienced a rise in net sales, but operating profit fell sharply due to increased R&D expenses and the impact of drug price revisions. Looking ahead, Meiji Holdings remains focused on its 2026 Medium-Term Business Plan, with expectations for continued growth in certain segments despite ongoing challenges in others.